BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 105041)

  • 1. Demonstration of hepatitis B e antigen in the core of Dane particles.
    Takahashi K; Akahane Y; Gotanda T; Mishiro T; Imai M; Miyakawa Y; Mayumi M
    J Immunol; 1979 Jan; 122(1):275-9. PubMed ID: 105041
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of hepatitis B e antigen (HBeAg) in association with intact Dane particles.
    Ohori H; Onodera S; Ishida N
    J Gen Virol; 1979 May; 43(2):423-7. PubMed ID: 113499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characterization of particles found in clinical cases of viral hepatitis: coronavirus-like particles, Australia antigen and Dane particles].
    Ackermann HW; Cherchel G; Valet JP; Matte J; Moorjani S; Higgins R
    Can J Microbiol; 1974 Feb; 20(2):193-203. PubMed ID: 4132609
    [No Abstract]   [Full Text] [Related]  

  • 4. Full and empty particles of hepatitis B virus in hepatocytes from patients with HBsAg-positive chronic active hepatitis.
    Sakamoto Y; Yamada G; Mizuno M; Nishihara T; Kinoyama S; Kobayashi T; Takahashi T; Nagashima H
    Lab Invest; 1983 Jun; 48(6):678-82. PubMed ID: 6855194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale isolation of Dane particles from plasma containing hepatitis B antigen and deomnstration of circular double-stranded DNA molecule extruding directly from their cores.
    Takahashi T; Nakagawa S; Hashimoto T; Takahashi K; Imai M
    J Immunol; 1976 Oct; 117(4):1392-7. PubMed ID: 977955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of dane particles with e antigen in the serum of asymptomatic carriers of hepatitis B surface antigen.
    Takahashi K; Imai M; Tsuda F; Takahashi T; Miyakawa Y
    J Immunol; 1976 Jul; 117(1):102-5. PubMed ID: 819577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full and empty Dane particles in chronic hepatitis B virus infection: relation to hepatitis B e antigen and presence of liver damage.
    Alberti A; Diana S; Scullard GH; Eddleston WF; Williams R
    Gastroenterology; 1978 Nov; 75(5):869-74. PubMed ID: 700329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathology of hepatitis B.
    Bianchi L; Gudat F
    Prog Liver Dis; 1979; 6():371-92. PubMed ID: 396564
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production in yeast of hepatitis B surface antigen by R-DNA technology.
    De Wilde M; Cabezon T; Harford N; Rutgers T; Simoen E; Van Wijnendaele F
    Dev Biol Stand; 1985; 59():99-107. PubMed ID: 4007280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of Australia antigen.
    Brzosko WJ; Mäntyjärvi RA; Madaliński K
    Acta Virol; 1972 Sep; 16(5):440-3. PubMed ID: 4404103
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Delta infection in HBsAg carriers].
    Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and biophysical characterization of hepatitis B antigen.
    Kim CY; Tilles JG
    J Clin Invest; 1973 May; 52(5):1176-86. PubMed ID: 4121700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of 'e' antigen associated with hepatitis B.
    Tedder RS; Bull FG
    Clin Exp Immunol; 1979 Mar; 35(3):380-9. PubMed ID: 110505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heterogeneity of host response to hepatitis B virus].
    Sarno EN; Ruzany F; Vieira LM; Landmann J
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):303-9. PubMed ID: 7167709
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation of a dane core (hepatitis B) antigen from human plasma.
    Fauvel M; Babiuk L; Sheaff ET; Spence L
    Can J Microbiol; 1975 Jun; 21(6):905-10. PubMed ID: 1097073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Destroying of antigenicity and influencing the immunochemical reactivity of hepatitis B virus antigens (HBsAg, HBcAg and HBeAg) through disinfectants--a proposed method for testing (author's transl)].
    Frösner G; Jentsch G; Uthemann H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1982 Apr; 176(1):1-14. PubMed ID: 6180573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis-associated antigen: purification and properties].
    Gerlich W; May G
    Zentralbl Bakteriol Orig A; 1973 Jun; 224(1):49-60. PubMed ID: 4147404
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medical topics. Hepatic vein obstruction caused by herb tea. Relationship between Hbe antigen and s antigen carriers].
    Shibusawa K
    Kango; 1984 Apr; 36(4):92-3. PubMed ID: 6566881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.